AUBAGIO Australia - English - Department of Health (Therapeutic Goods Administration)

aubagio

sanofi-aventis australia pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; magnesium stearate; sodium starch glycollate; maize starch; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - aubagio is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

AGIOLAX PICO Ireland - English - HPRA (Health Products Regulatory Authority)

agiolax pico

madaus gmbh - sodium picosulfate - lozenges - 5 milligram

Agiolax granules Australia - English - Department of Health (Therapeutic Goods Administration)

agiolax granules

sfi australasia - ispaghula husk dry, quantity: 22 mg/g; senna fruit tinnevelly dry, quantity: 100 mg/g (equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 3 mg/g); psyllium seed dry, quantity: 520 mg/g - granules - excipient ingredients: iron oxide red; iron oxide yellow; purified talc; sage oil spanish; peppermint oil; iron oxide black; caraway oil; sucrose; hard paraffin; liquid paraffin; acacia - maintain/support general health and wellbeing ; decrease/reduce/relieve constipation ; traditionally used in western herbal medicine to decrease/reduce/relieve constipation ; traditionally used in western herbal medicine to aperient/laxative ; aperient/laxative ; helps reduce occurrence of constipation ; increase bowel movements by increasing stool bulk ; maintain/support bowel regularity by increasing stool bulk ; promote/increase bowel evacuation ; traditionally used in western herbal medicine to promote/increase bowel evacuation ; stimulant laxative ; traditionally used in western herbal medicine to stimulant laxative ; maintain/support bowel regularity ; traditionally used in western herbal medicine to enhance/improve/promote/increase bowel waste elimination ; maintain/support healthy bowel/colon function

TIBSOVO- ivosidenib tablet, film coated United States - English - NLM (National Library of Medicine)

tibsovo- ivosidenib tablet, film coated

agios pharmaceuticals, inc. - ivosidenib (unii: q2pcn8mam6) (ivosidenib - unii:q2pcn8mam6) - tibsovo is indicated for the treatment of newly-diagnosed acute myeloid leukemia (aml) with a susceptible isocitrate dehydrogenase-1 (idh1) mutation as detected by an fda-approved test in adult patients who are ≥ 75 years old or who have comorbidities that preclude use of intensive induction chemotherapy [see dosage and administration (2.1), clinical pharmacology (12.1) and clinical studies (14.1)]. tibsovo is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (aml) with a susceptible isocitrate dehydrogenase-1 (idh1) mutation as detected by an fda-approved test [see dosage and administration (2.1), clinical pharmacology (12.1) and clinical studies (14.2)]. none. risk summary based on animal embryo-fetal toxicity studies, tibsovo may cause fetal harm when administered to a pregnant woman. there are no available data on tibsovo use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. in animal embryo-fetal toxicity studies, ora

AUBAGIO FILM-COATED TABLETS 14mg Singapore - English - HSA (Health Sciences Authority)

aubagio film-coated tablets 14mg

sanofi-aventis singapore pte. ltd. - teriflunomide - tablet, film coated - teriflunomide 14.0mg